Drug Target Review2025-12-01T08:30:13
Scientists have used human stem cell–derived kidney organoids to uncover how abnormal Hippo signalling drives scarring in nephronophthisis, a rare genetic kidney disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-09-24T06:30:00Z
Contributor Dr Dan Benjamin, Drug Target Review
2025-09-18T12:00:00
Sponsored by Benchling
2026-09-18T15:56:00
Contributor Dr Garegin Papoian, Drug Target Review
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2026-06-29T06:49:00
Contributor Laura Alvarez, Drug Target Review
2026-08-06T06:08:00
Author Dr Jonathan Cohen-Gold
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
Site powered by Webvision Cloud